chaarted2: cabazitaxel plus abiraterone vs. abiraterone alone for metastatic crpc
Published 3 months ago • 80 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
4:06
combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
-
5:59
apalutamide in combination with abiraterone acetate, docetaxel and prednisone for mcrpc
-
1:53
abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
-
3:14
treatment with abiraterone acetate without steroids in mcrpc
-
2:05
abiraterone in metastatic castration-sensitive prostate cancer
-
0:44
peace-1: abiraterone plus prednisone, adt and docetaxel in mcspc
-
2:12
abiraterone for metastatic, hormone sensitive, prostate cancer
-
12:48
stampede: abiraterone result (full version)
-
3:55
abiraterone plus prednisone in crpc: factors to consider
-
2:50
abiraterone: approval and use
-
2:05
dr. kohli on sequencing concerns in metastatic hormone-sensitive prostate cancer
-
1:50
a phase i trial of apalutamide plus abiraterone acetate, docetaxel, and prednisone in mcrpc
-
6:21
stampede: abiraterone results (short version)
-
0:53
dr. attard on abiraterone
-
1:17
abiraterone for the treatment of cn1 prostate cancer
-
5:16
exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone